Literature DB >> 8364910

IA-1, a new marker for neuroendocrine differentiation in human lung cancer cell lines.

M S Lan1, E K Russell, J Lu, B E Johnson, A L Notkins.   

Abstract

IA-1 is a recently isolated novel complementary DNA which encodes a protein of 510 amino acids that contains both a zinc finger DNA-binding domain and a putative prohormone domain. mRNA expression of IA-1 has been found thus far only in tumors of neuroendocrine origin. In this report we describe the expression of IA-1 mRNA in a panel of 64 human lung cancer cell lines. IA-1 mRNA was detected by Northern blot analysis in 97% (30 of 31) of small cell lung cancer cell lines. In contrast, IA-1 mRNA was detected in only 13% (4 of 30) of non-small cell lung cancer cell lines. Nine of the 30 (30%) expressed either chromogranin A mRNA or produced L-dopa decarboxylase. Four of these 9 (44%) had detectable levels of IA-1 mRNA. In most of the lung cancer cell lines examined, IA-1 showed high concordance with the other neuroendocrine markers, L-dopa decarboxylase, and chromogranin A. The one exception was a variant small cell lung cancer cell line which expressed low or nondetectable levels of L-dopa decarboxylase. IA-1 is a candidate marker of neuroendocrine differentiation of human lung tumors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8364910

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  27 in total

1.  Integrative epigenomic and genomic analysis of malignant pheochromocytoma.

Authors:  Johanna Sandgren; Robin Andersson; Alvaro Rada-Iglesias; Stefan Enroth; Goran Akerstrom; Jan P Dumanski; Jan Komorowski; Gunnar Westin; Claes Wadelius
Journal:  Exp Mol Med       Date:  2010-07-31       Impact factor: 8.718

2.  Inhibition of touch cell fate by egl-44 and egl-46 in C. elegans.

Authors:  J Wu; A Duggan; M Chalfie
Journal:  Genes Dev       Date:  2001-03-15       Impact factor: 11.361

3.  NeuroD1/E47 regulates the E-box element of a novel zinc finger transcription factor, IA-1, in developing nervous system.

Authors:  Mary B Breslin; Min Zhu; Michael S Lan
Journal:  J Biol Chem       Date:  2003-07-30       Impact factor: 5.157

4.  Zinc finger transcription factor INSM1 interrupts cyclin D1 and CDK4 binding and induces cell cycle arrest.

Authors:  Tao Zhang; Wei-Dong Liu; Nicolle A Saunee; Mary B Breslin; Michael S Lan
Journal:  J Biol Chem       Date:  2009-01-05       Impact factor: 5.157

5.  The Gfi-1 proto-oncoprotein contains a novel transcriptional repressor domain, SNAG, and inhibits G1 arrest induced by interleukin-2 withdrawal.

Authors:  H L Grimes; T O Chan; P A Zweidler-McKay; B Tong; P N Tsichlis
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

6.  The Gfi-1B proto-oncoprotein represses p21WAF1 and inhibits myeloid cell differentiation.

Authors:  B Tong; H L Grimes; T Y Yang; S E Bear; Z Qin; K Du; W S El-Deiry; P N Tsichlis
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

7.  Neuroendocrine differentiation factor, IA-1, is a transcriptional repressor and contains a specific DNA-binding domain: identification of consensus IA-1 binding sequence.

Authors:  Mary B Breslin; Min Zhu; Abner L Notkins; Michael S Lan
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

Review 8.  Insulinoma-Associated-1: From Neuroendocrine Tumor Marker to Cancer Therapeutics.

Authors:  Chiachen Chen; Abner L Notkins; Michael S Lan
Journal:  Mol Cancer Res       Date:  2019-05-21       Impact factor: 5.852

9.  Expression of insulinoma-associated 2 (INSM2) in pancreatic islet cells is regulated by the transcription factors Ngn3 and NeuroD1.

Authors:  Tao Cai; Xiang Chen; Rennian Wang; Huan Xu; Yuhui You; Tao Zhang; Michael S Lan; Abner L Notkins
Journal:  Endocrinology       Date:  2011-02-22       Impact factor: 4.736

10.  Adenoviral insulinoma-associated protein 1 promoter-driven suicide gene therapy with enhanced selectivity for treatment of neuroendocrine cancers.

Authors:  Victoria Akerstrom; Chiachen Chen; Michael S Lan; Mary B Breslin
Journal:  Ochsner J       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.